Abstract:We report on a miniature label-free imaging system for monitoring brain blood flow and blood oxygenation changes in awake, freely behaving rats. The device, weighing 15 grams, enables imaging in a ∼ 2 × 2 mm field of view with 4.4 µm lateral resolution and 1 − 8 Hz temporal sampling rate. The imaging is performed through a chronically-implanted cranial window that remains optically clear between 2 to > 6 weeks after the craniotomy. This imaging method is well suited for longitudinal studies of chronic models of brain diseases and disorders. In this work, it is applied to monitoring neurovascular coupling during drug-induced absence-like seizures 6 weeks following the craniotomy.
Abstract-Wavelength conversion by difference frequency generation is demonstrated in domain-disordered quasi-phase matched waveguides. The waveguide structure consisted of a GaAs/AlGaAs superlattice core that was periodically intermixed by ion-implantation. For quasi-phase matching periods of 3.0-3.8 µm, degeneracy pump wavelengths were found by secondharmonic generation experiments for fundamental wavelengths between 1520-1620 nm in both type-I and type-II configurations. In the difference frequency generation experiments, output powers up to 8.7 nW were generated for the type-I phase matching interaction, and 1.9 nW for the type-II interaction. The conversion bandwidth was measured to be over 100 nm covering the C, L, and U optical communications bands, which agrees with predictions.
We report a single-beam, differential z-scan technique with improved sensitivity for the determination of nonlinear absorption and refraction of materials. A sample is scanned in the direction of beam propagation as usual, but, in addition, its longitudinal position is dithered, producing a detector signal proportional to the spatial derivative of only the nonlinear transmission and therefore giving a background-free signal; the nonlinear transmission for any spatial position of the sample can be recovered by simple integration. For both open and closed aperture scans in GaP, we find an improvement in the signal-to-noise ratio of >5 x compared with a balanced z-scan setup, but this can be improved with apparatus optimization. Nonlinear phase distortions
The integrity of the blood brain barrier (BBB) can contribute to the development of many brain disorders. We evaluate laser speckle contrast imaging (LSCI) as an intrinsic modality for monitoring BBB disruptions through simultaneous fluorescence and LSCI with vertical cavity surface emitting lasers (VCSELs). We demonstrated that drug-induced BBB opening was associated with a relative change of the arterial and venous blood velocities. Cross-sectional flow velocity ratio (veins/arteries) decreased significantly in rats treated with BBB-opening drugs, ≤0.81 of initial values.
Abstract:Laser Speckle Contrast Imaging (LSCI) is a flexible, easyto-implement technique for measuring blood flow speeds in-vivo. In order to obtain reliable quantitative data from LSCI the object must remain in the focal plane of the imaging system for the duration of the measurement session. However, since LSCI suffers from inherent frame-to-frame noise, it often requires a moving average filter to produce quantitative results. This frame-to-frame noise also makes the implementation of rapid autofocus system challenging. In this work, we demonstrate an autofocus method and system based on a novel measure of misfocus which serves as an accurate and noise-robust feedback mechanism. This measure of misfocus is shown to enable the localization of best focus with sub-depth-of-field sensitivity, yielding more accurate estimates of blood flow speeds and blood vessel diameters.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.